<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T14:52:53Z</responseDate>
  <request identifier="oai:figshare.com:article/33999046" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33999046</identifier>
        <datestamp>2026-09-25T17:38:37Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_8</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Data dictionary.&lt;/p&gt;</dc:title>
          <dc:creator>Mateusz Bartoszewicz (18928309)</dc:creator>
          <dc:creator>Marta Krysik (25111381)</dc:creator>
          <dc:creator>Sławomir Lech Czaban (18928321)</dc:creator>
          <dc:creator>Jerzy Robert Ładny (14049981)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>intensive care units</dc:subject>
          <dc:subject>independent risk estimate</dc:subject>
          <dc:subject>identify independent associations</dc:subject>
          <dc:subject>clinically classified cases</dc:subject>
          <dc:subject>3231 records remained</dc:subject>
          <dc:subject>75 &amp;# 8211</dc:subject>
          <dc:subject>55 &amp;# 8211</dc:subject>
          <dc:subject>20 &amp;# 8211</dc:subject>
          <dc:subject>15 &amp;# 8211</dc:subject>
          <dc:subject>two bacterial species</dc:subject>
          <dc:subject>4 %&amp;# 8722</dc:subject>
          <dc:subject>distinct admission profile</dc:subject>
          <dc:subject>90 ), obesity</dc:subject>
          <dc:subject>observed icu stay</dc:subject>
          <dc:subject>mean icu stay</dc:subject>
          <dc:subject>ci &amp;# 8722</dc:subject>
          <dc:subject>risk difference 3</dc:subject>
          <dc:subject>least 48 hours</dc:subject>
          <dc:subject>clinical characteristics available</dc:subject>
          <dc:subject>3 versus 13</dc:subject>
          <dc:subject>7 &amp;# 8211</dc:subject>
          <dc:subject>10 &amp;# 179</dc:subject>
          <dc:subject>characterize bacterial cauti</dc:subject>
          <dc:subject>2 percentage points</dc:subject>
          <dc:subject>xlink "&gt; catheter</dc:subject>
          <dc:subject>3 %; 95</dc:subject>
          <dc:subject>icu stay</dc:subject>
          <dc:subject>&amp;# 8805</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>bacterial catheter</dc:subject>
          <dc:subject>versus 45</dc:subject>
          <dc:subject>difference 14</dc:subject>
          <dc:subject>bacterial cauti</dc:subject>
          <dc:subject>4 %).</dc:subject>
          <dc:subject>icu cohort</dc:subject>
          <dc:subject>admission characteristics</dc:subject>
          <dc:subject>8 ),</dc:subject>
          <dc:subject>catheter exposure</dc:subject>
          <dc:subject>icu patients</dc:subject>
          <dc:subject>ci 8</dc:subject>
          <dc:subject>ci 11</dc:subject>
          <dc:subject>skewed biomarkers</dc:subject>
          <dc:subject>june 2023</dc:subject>
          <dc:subject>january 2017</dc:subject>
          <dc:subject>interquartile ranges</dc:subject>
          <dc:subject>female sex</dc:subject>
          <dc:subject>common device</dc:subject>
          <dc:description>&lt;div&gt;
&lt;p&gt;Background&lt;/p&gt;&lt;p&gt;Catheter-associated urinary tract infection (CAUTI) is a common device-associated complication in intensive care units (ICUs).&lt;/p&gt;
&lt;p&gt;Objective&lt;/p&gt;&lt;p&gt;To characterize bacterial CAUTI in an ICU cohort and identify independent associations with demographic and clinical characteristics available at or before ICU admission.&lt;/p&gt;
&lt;p&gt;Methods&lt;/p&gt;&lt;p&gt;This single-center retrospective cohort included 3326 index ICU admissions from January 2017 through June 2023. After exclusion of 95 fungal-only clinically classified cases, 3231 records remained. Bacterial CAUTI required compatible clinical findings, at least 48 hours of catheter exposure, and ≥10³ CFU/mL of one or two bacterial species. All patients were catheterized throughout the observed ICU stay. The primary logistic model included only admission characteristics; ICU stay/catheter duration was descriptive because exact CAUTI onset dates were unavailable. Skewed biomarkers were summarized with medians, interquartile ranges, and Mann-Whitney tests.&lt;/p&gt;
&lt;p&gt;Results&lt;/p&gt;&lt;p&gt;Bacterial CAUTI occurred in 301 patients (9.3%; 95% CI 8.4%−10.4%). Mean ICU stay/catheter duration was 28.3 versus 13.6 days (difference 14.8 days; 95% CI 11.7–17.8), but duration was not interpreted as an independent risk estimate. Mortality was 49.2% versus 45.9% (risk difference 3.2 percentage points; 95% CI −2.7 to 9.1), and bacterial CAUTI was not associated with death after adjustment for admission characteristics (OR 0.95; 95% CI 0.75–1.22). Female sex (OR 1.48; 95% CI 1.15–1.90), obesity (OR 1.62; 95% CI 1.20–2.19), and COVID-19 (OR 2.16; 95% CI 1.55–3.00) were independently associated. At least one resistance phenotype was recorded in 200 patients (66.4%).&lt;/p&gt;
&lt;p&gt;Conclusions&lt;/p&gt;&lt;p&gt;Bacterial CAUTI was associated with a distinct admission profile and longer observed ICU stay/catheter exposure, although causal direction could not be determined. It was not associated with adjusted in-hospital mortality.&lt;/p&gt;&lt;/div&gt;</dc:description>
          <dc:date>2026-09-25T17:38:31Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0358796.s004</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Data_dictionary_p_/33999046</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
